Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo
Authors
Keywords
-
Journal
Molecular Therapy-Methods & Clinical Development
Volume 30, Issue -, Pages 546-557
Publisher
Elsevier BV
Online
2023-08-24
DOI
10.1016/j.omtm.2023.08.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipid Nanoparticles Allow Efficient and Harmless Ex Vivo Gene Editing of Human Hematopoietic Cells
- (2023) Valentina Vavassori et al. BLOOD
- Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
- (2023) Samuele Ferrari et al. Cell Stem Cell
- Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
- (2022) Samuele Ferrari et al. Cell Stem Cell
- Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
- (2021) Valentina Vavassori et al. EMBO Molecular Medicine
- TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
- (2021) Nisha B. Nagarsheth et al. NATURE MEDICINE
- Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study
- (2019) Francesca Ferrua et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application
- (2019) Juliane W. Schott et al. Molecular Therapy-Methods & Clinical Development
- Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
- (2018) Caroline Y. Kuo et al. Cell Reports
- Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
- (2018) Carolina Petrillo et al. Cell Stem Cell
- Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation
- (2017) M. Teresa de la Morena et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome
- (2016) Nicholas Hubbard et al. BLOOD
- Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
- (2016) John Attanasio et al. IMMUNITY
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Hyper IgM Syndromes
- (2013) Nashmia Qamar et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates
- (2012) Hichem Lahouassa et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now